NuvaTimeTM Reminder Tool

NuvaTime can help you remember your important dates.

With NuvaTime you can:

  • Get reminders when it's time to insert and remove NuvaRing and when to refill your prescription.
  • Get reminders at home or on-the-go.
  • Put all your reminders in your Outlook, iCal, Google, and Yahoo! calendars.

NuvaTime is easy to set up in just a few steps. Select the reminders you want to help you remember when to insert and remove NuvaRing and when to refill your prescription. Then download them to your electronic calendar. Before completing the following screens, remember to make sure you're logged into your e-mail account so your reminders are recorded properly in your calendar.

Note: The information you enter regarding your reminder needs will not be shared or seen by anyone other than you.

Select the reminders you want

Please select the type of reminder(s) you'd like to receive

Insertion & Removal Reminders

Select your insertion date

Please select an insertion date

XX/XX/XXXX  Automatically set 21 days after

Refill Reminders

Select when you'd like to receive refill reminders. Remember that your insurance plan may determine how often you can refill. Plans may vary on the frequency with which they will cover refills.

Please select a reminder date

Select the Calendar Type

Download calendar reminders

Download calendar reminder

Click to download insertion and removal reminders. Once set, reminders will automatically recur on your calendar until you change or delete them.

Click to download refill reminder. Once set, refill reminder will automatically recur on your calendar until you change or delete it.

Click to download reminders. Once set, the reminders will automatically recur on your calendar until you change or delete them.

NuvaRing (etonogestrel/ethinyl estradiol vaginal ring) is a flexible birth control vaginal ring used to prevent pregnancy. Available by prescription only.

Do not use NuvaRing (etonogestrel/ethinyl estradiol vaginal ring) if you smoke cigarettes and are over age 35. Smoking increases your risk of serious heart and blood vessel problems from combination hormonal contraceptives (CHCs) including heart attack, blood clots, or stroke which can be fatal. This risk increases with age and the number of cigarettes smoked.

  • The use of a CHC, like NuvaRing, is associated with increased risks of several serious side effects, including blood clots, stroke, or heart attack. NuvaRing is not for women with a history of these conditions or any condition that makes your blood more likely to clot. The risk of getting blood clots may be greater with the type of progestin in NuvaRing than with some other progestins in certain low-dose birth control pills. The risk of blood clots is highest when you first start using CHCs and when you restart the same or different CHC after not using it for a month or more.
  • NuvaRing is also not for women with high blood pressure that medicine can't control; diabetes with kidney, eye, nerve, or blood vessel damage; certain kinds of severe migraine headaches; liver disease or liver tumors; unexplained vaginal bleeding; breast cancer or any cancer that is sensitive to female hormones; or if you are or may be pregnant.
  • NuvaRing does not protect against HIV infection (AIDS) and other sexually transmitted infections.
  • The most common side effects reported by users of NuvaRing are irritation inside your vagina or on your cervix; headache (including migraine); mood changes (including depression); the ring slipping out or causing discomfort; nausea and vomiting; vaginal discharge; weight gain; vaginal discomfort; breast pain, discomfort, or tenderness; painful menstrual periods; abdominal pain; acne; and less sexual desire.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit or call 1-800-FDA-1088.

Please read the Patient Information for NuvaRing (etonogestrel/ethinyl estradiol vaginal ring), including the information about the increased risk of serious cardiovascular side effects, especially in women who smoke, and discuss it with your health care provider. The physician Prescribing Information is also available.